Abstract:Purpose: USP has formed Advisory Panels to ensure the integrity of laboratory procedures for non-oral routes of administration and expects that the panels will recommend performance tests (performance qualification, PQ) for these dosage forms as well as performance verification tests (PVT) for those PQ tests. An integral part of PQ is PVT, in which a standard formulation is first tested in a metrologically sound collaborative study to set acceptance criteria. Individual laboratories can then test the performance of their product by comparing their results to those obtained from the USP collaborative study. These studies are guided by metrological principles, e.g., those of the International Organization for Standardization (ISO) 43-1, which succinctly states that "one of the main uses of proficiency testing schemes is to assess laboratories' ability to perform tests competently." Materials and methods: Four laboratories conducted two collaborative studies to determine the reliability and reproducibility--understood in metrological terms--of release rates from semisolid dosage forms using the vertical diffusion cell (VDC). Results: The experiments reported here from the second study found that the major contributor to variability is the interlaboratory component that may include intermediate precision considerations other than analyst. Because all laboratories used the same model equipment, one might expect that the observed reproducibility CV was lower than if the laboratories used different models or equipment made by different manufacturers. Also, more variability was observed with the creams than the other dosage forms. Conclusions: The results from the preliminary collaborative study found inconsistency among the laboratories. After operator training, the results from the second study were more consistent, suggesting the initial results were associated with variations among the laboratories in performing the methods and procedures and conducting the protocols. Those results emphasize that although the in vitro release procedure is simple and reproducible, training is needed. The data presented suggest that testing of in vitro release by VDCs should be considered as a PVT for topical semisolid dosage forms. Thus, a standard semisolid product is needed, along with a means for setting acceptance criteria. The SUPAC-SS Guidance may be helpful in the latter regard.

In vitro Dermal Absorption: Sample Application and Seal Quality in a Franz Diffusion Cell System

In vitro skin puncture methodology for material characterization

Method to determine the impact of substantivity on ex vivo skin-permeation

An innovative device for in vivo and in vitro study of fragrance evaporation after application on skin or model surfaces

Reliability and reproducibility of vertical diffusion cells for determining release rates from semisolid dosage forms

In vitro permeation testing for the evaluation of drug delivery to the skin

Expert Consensus on the Technical Specifications of the in Vitro Skin Penetration Test of Cosmetic Product by Franz Diffusion Cell

Optimization of skin sampling based on tape stripping for lipidome analysis by nanoflow ultrahigh performance liquid chromatography-tandem mass spectrometry

Dermal exposure to chemicals - evaluation of skin barrier damage

Inter-laboratory skin distribution study of 4-n-butyl resorcinol: The importance of liquid chromatography/mass spectrometry (HPLC-MS/MS) bioanalytical validation

Evaluation of a New In Chemico Skin Corrosion Test

Comparing Surfactant Penetration into Human Skin and Resulting Skin Dryness Using In Vivo and Ex Vivo Methods.

Confocal Raman spectroscopy coupled with in vitro permeation testing to study the effects of formalin fixation on the skin barrier function of reconstructed human epidermis

Pre-Analytical Sample Quality: Metabolite Ratios as an Intrinsic Marker for Prolonged Room Temperature Exposure of Serum Samples

Stepwise Protocols for Preparation and Use of Porcine Ear Skin for in Vitro Skin Permeation Studies Using Franz Diffusion Cells

Assessment of skin permeability to topically applied drugs by skin impedance and admittance

Validation of an In vitro-in vivo Assay System for Evaluation of Transdermal Delivery of Caffeine

Application of In Vitro Methods in Preclinical Safety Assessment of Skin Care Products

Effect of Application Amounts on In Vitro Dermal Absorption Test Using Caffeine and Testosterone

An Analytical Target Profile for the Development of an In Vitro Release Test Method and Apparatus Selection in the Case of Semisolid Topical Formulations

Interlaboratory Validation of the in vitro Eye Irritation Tests for Cosmetic Ingredients. (4) Haemoglobin Denaturation Test